{"id": "Vc3IaCIAAAAJ", "citedby": 32872, "citedby5y": 9405, "hindex": 92, "hindex5y": 52, "i10index": 232, "i10index5y": 160, "coauthors": [], "name": "Paul Watkins", "affiliation": "Professor of Pharmacy, Medicine and Public Health University of North Carolina, Chapel Hill", "interests": ["Drug-Induced Liver Injury"], "cites_per_year": {"1987": 95, "1988": 113, "1989": 170, "1990": 199, "1991": 198, "1992": 262, "1993": 296, "1994": 292, "1995": 356, "1996": 464, "1997": 460, "1998": 571, "1999": 734, "2000": 762, "2001": 784, "2002": 957, "2003": 1128, "2004": 1152, "2005": 1282, "2006": 1271, "2007": 1197, "2008": 1360, "2009": 1242, "2010": 1394, "2011": 1438, "2012": 1456, "2013": 1634, "2014": 1638, "2015": 1558, "2016": 1645, "2017": 1658, "2018": 1813, "2019": 1882, "2020": 825}, "publications": [{"bib": {"title": "Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:u5HHmVD_uO8C", "citedby": "2266"}, {"bib": {"title": "Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug\u2013drug interaction", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:u-x6o8ySG0sC", "citedby": "1011"}, {"bib": {"title": "Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Tyk-4Ss8FVUC", "citedby": "826"}, {"bib": {"title": "Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:qjMakFHDy7sC", "citedby": "812"}, {"bib": {"title": "Role of intestinal P\u2010glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:d1gkVwhDpl0C", "citedby": "793"}, {"bib": {"title": "Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:9yKSN-GCB0IC", "citedby": "753"}, {"bib": {"title": "Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:2osOgNQ5qMEC", "citedby": "708"}, {"bib": {"title": "Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Y0pCki6q_DkC", "citedby": "672"}, {"bib": {"title": "Case definition and phenotype standardization in drug\u2010induced liver injury", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:YOwf2qJgpHMC", "citedby": "613"}, {"bib": {"title": "Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:UeHWp8X0CEIC", "citedby": "594"}, {"bib": {"title": "Hepatic dysfunction associated with troglitazone", "year": "1998"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:zYLM7Y9cAGgC", "citedby": "553"}, {"bib": {"title": "Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.", "year": "1987"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:IjCSPb-OGe4C", "citedby": "544"}, {"bib": {"title": "The barrier function of CYP3A4 and P-glycoprotein in the small bowel", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WF5omc3nYNoC", "citedby": "474"}, {"bib": {"title": "Liver transplantation for acute liver failure from drug induced liver injury in the United States", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Se3iqnhoufwC", "citedby": "466"}, {"bib": {"title": "First-pass metabolism of cyclosporin by the gut", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:YsMSGLbcyi4C", "citedby": "466"}, {"bib": {"title": "Non-invasive tests of CYP3A enzymes", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:W7OEmFMy1HYC", "citedby": "459"}, {"bib": {"title": "CYP 3A gene expression in human gut epithelium", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_FxGoFyzp5QC", "citedby": "448"}, {"bib": {"title": "Identification of an inducible form of cytochrome P-450 in human liver", "year": "1985"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:eQOLeE2rZwMC", "citedby": "430"}, {"bib": {"title": "Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by \u2026", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ufrVoPGSRksC", "citedby": "424"}, {"bib": {"title": "Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:LkGwnXOMwfcC", "citedby": "408"}, {"bib": {"title": "Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.", "year": "1989"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:roLk4NBRz8UC", "citedby": "376"}, {"bib": {"title": "Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1\u03b1, 25-dihydroxyvitamin D3", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hqOjcs7Dif8C", "citedby": "360"}, {"bib": {"title": "Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_kc_bZDykSQC", "citedby": "359"}, {"bib": {"title": "Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WA5NYHcadZ8C", "citedby": "353"}, {"bib": {"title": "Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p", "year": "1985"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:UebtZRa9Y70C", "citedby": "351"}, {"bib": {"title": "Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:L8Ckcad2t8MC", "citedby": "341"}, {"bib": {"title": "The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:5nxA0vEk-isC", "citedby": "340"}, {"bib": {"title": "Common allelic variants of cytochrome P4503A4 and their prevalence in different populations", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:0EnyYjriUFMC", "citedby": "336"}, {"bib": {"title": "Drug-induced liver injury network (DILIN) prospective study", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ZeXyd9-uunAC", "citedby": "322"}, {"bib": {"title": "Drug\u2010induced liver injury: summary of a single topic clinical research conference", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Zph67rFs4hoC", "citedby": "322"}, {"bib": {"title": "6\u2032, 7\u2032\u2010Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P\u2010glycoprotein", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:8k81kl-MbHgC", "citedby": "298"}, {"bib": {"title": "Molecular and physical mechanisms of first-pass extraction", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:MXK_kJrjxJIC", "citedby": "295"}, {"bib": {"title": "Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:KlAtU1dfN6UC", "citedby": "292"}, {"bib": {"title": "Insulin Control of Glucose Metabolism in Man: A New Kinetic Analysis", "year": "1975"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:3fE2CSJIrl8C", "citedby": "287"}, {"bib": {"title": "Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:QIV2ME_5wuYC", "citedby": "265"}, {"bib": {"title": "Identification of a polymorphically expressed member of the human cytochrome P-450III family.", "year": "1989"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kNdYIx-mwKoC", "citedby": "264"}, {"bib": {"title": "Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat.", "year": "1985"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ULOm3_A8WrAC", "citedby": "254"}, {"bib": {"title": "Role of cytochromes P45O in drug metabolism and hepatotoxicity", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:aqlVkmm33-oC", "citedby": "247"}, {"bib": {"title": "Seville orange juice\u2010felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:M3ejUd6NZC8C", "citedby": "244"}, {"bib": {"title": "The human CYP3A subfamily: practical considerations", "year": "2000"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4TOpqqG69KYC", "citedby": "242"}, {"bib": {"title": "Drug metabolism by cytochromes P450 in the liver and small bowel.", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:qxL8FJ1GzNcC", "citedby": "242"}, {"bib": {"title": "Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase", "year": "1986"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:mVmsd5A6BfQC", "citedby": "225"}, {"bib": {"title": "The effect of an individual\u2019s cytochrome CYP3A4 activity on docetaxel clearance", "year": "2000"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Wp0gIr-vW9MC", "citedby": "223"}, {"bib": {"title": "Hepatic but not intestinal CYP3A4 displays dose\u2010dependent induction by efavirenz in humans", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:7PzlFSSx8tAC", "citedby": "219"}, {"bib": {"title": "Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver", "year": "1986"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4DMP91E08xMC", "citedby": "214"}, {"bib": {"title": "Hepatic histological findings in suspected drug\u2010induced liver injury: systematic evaluation and clinical associations", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:dfsIfKJdRG4C", "citedby": "211"}, {"bib": {"title": "Bimodal distribution of renal cytochrome P450 3A activity in humans.", "year": "1996"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:9ZlFYXVOiuMC", "citedby": "209"}, {"bib": {"title": "Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture.", "year": "1986"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:dhFuZR0502QC", "citedby": "191"}, {"bib": {"title": "Metabolomics in toxicology: preclinical and clinical applications", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:TFP_iSt0sucC", "citedby": "182"}, {"bib": {"title": "Polymerase \u03b3 Gene POLG determines the risk of sodium valproate\u2010induced liver toxicity", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:GnPB-g6toBAC", "citedby": "176"}, {"bib": {"title": "Idiosyncratic liver injury: challenges and approaches", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:-f6ydRqryjwC", "citedby": "174"}, {"bib": {"title": "A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice\u2013felodipine interaction", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HDshCWvjkbEC", "citedby": "168"}, {"bib": {"title": "Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1\u03b1, 25-dihydroxyvitamin D3: implications for drug-induced osteomalacia", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:r0BpntZqJG4C", "citedby": "167"}, {"bib": {"title": "CYP3A5 genotype predicts renal CYP3A activity and blood pressure  in healthy adults", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:mB3voiENLucC", "citedby": "156"}, {"bib": {"title": "Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:R3hNpaxXUhUC", "citedby": "156"}, {"bib": {"title": "Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:isC4tDSrTZIC", "citedby": "155"}, {"bib": {"title": "Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:IWHjjKOFINEC", "citedby": "155"}, {"bib": {"title": "Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug\u2010induced liver injury", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:j3f4tGmQtD8C", "citedby": "149"}, {"bib": {"title": "Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat.", "year": "1986"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hC7cP41nSMkC", "citedby": "149"}, {"bib": {"title": "The erythromycin breath test predicts the clearance of midazolam", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hFOr9nPyWt4C", "citedby": "148"}, {"bib": {"title": "Comparison of urinary 6\u2010\u03b2\u2010cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:qUcmZB5y_30C", "citedby": "147"}, {"bib": {"title": "Use of pharmaco\u2010metabonomics for early prediction of acetaminophen\u2010induced hepatotoxicity in humans", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:YFjsv_pBGBYC", "citedby": "143"}, {"bib": {"title": "Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults", "year": "2000"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:RHpTSmoSYBkC", "citedby": "140"}, {"bib": {"title": "In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_Qo2XoVZTnwC", "citedby": "133"}, {"bib": {"title": "Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:e5wmG9Sq2KIC", "citedby": "132"}, {"bib": {"title": "Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:K3LRdlH-MEoC", "citedby": "130"}, {"bib": {"title": "Blood gene expression signatures predict exposure levels", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:iH-uZ7U-co4C", "citedby": "128"}, {"bib": {"title": "The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:TQgYirikUcIC", "citedby": "125"}, {"bib": {"title": "Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4JMBOYKVnBMC", "citedby": "121"}, {"bib": {"title": "Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazole", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:M3NEmzRMIkIC", "citedby": "118"}, {"bib": {"title": "Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1) by bosentan: a mechanism for species differences in hepatotoxicity", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ns9cj8rnVeAC", "citedby": "117"}, {"bib": {"title": "Drug-related hepatotoxicity.", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:jgBuDB5drN8C", "citedby": "116"}, {"bib": {"title": "Drug safety sciences and the bottleneck in drug development", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:u_35RYKgDlwC", "citedby": "115"}, {"bib": {"title": "Induction of CYP3A4 by 1\u03b1, 25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hMod-77fHWUC", "citedby": "115"}, {"bib": {"title": "Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:k_IJM867U9cC", "citedby": "114"}, {"bib": {"title": "Severe acetaminophen toxicity in a patient receiving isoniazid", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:maZDTaKrznsC", "citedby": "113"}, {"bib": {"title": "The erythromycin breath test as a predictor of cyclosporine blood levels", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:bEWYMUwI8FkC", "citedby": "113"}, {"bib": {"title": "Using controlled clinical trials to learn more about acute drug\u2010induced liver injury", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:2P1L_qKh6hAC", "citedby": "110"}, {"bib": {"title": "Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:JV2RwH3_ST0C", "citedby": "110"}, {"bib": {"title": "Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:1yWc8FF-_SYC", "citedby": "110"}, {"bib": {"title": "MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:blknAaTinKkC", "citedby": "109"}, {"bib": {"title": "Clinical pattern of tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: analysis of clinical trials database", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:j8SEvjWlNXcC", "citedby": "107"}, {"bib": {"title": "The role of cytochromes P-450 in cyclosporine metabolism", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:J_g5lzvAfSwC", "citedby": "106"}, {"bib": {"title": "Drug interactions with herbal products and grapefruit juice: a conference report", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NMxIlDl6LWMC", "citedby": "104"}, {"bib": {"title": "Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:RYcK_YlVTxYC", "citedby": "103"}, {"bib": {"title": "Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:nRpfm8aw39MC", "citedby": "100"}, {"bib": {"title": "Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NaGl4SEjCO4C", "citedby": "100"}, {"bib": {"title": "Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:bFI3QPDXJZMC", "citedby": "99"}, {"bib": {"title": "[125I] 2-iodo-3, 7, 8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification.", "year": "1989"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:owLR8QvbtFgC", "citedby": "99"}, {"bib": {"title": "Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:BqipwSGYUEgC", "citedby": "97"}, {"bib": {"title": "Evaluation of drug-induced serious hepatotoxicity (eDISH)", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:rO6llkc54NcC", "citedby": "92"}, {"bib": {"title": "6\u2032 7\u2032\u2010Dihydroxybergamottin contributes to the grapefruit juice effect", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:RGFaLdJalmkC", "citedby": "92"}, {"bib": {"title": "The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:D03iK_w7-QYC", "citedby": "88"}, {"bib": {"title": "First-pass midazolam metabolism catalyzed by 1\u03b1, 25-dihydroxy vitamin D3-modified Caco-2 cell monolayers", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:lSLTfruPkqcC", "citedby": "88"}, {"bib": {"title": "Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:70eg2SAEIzsC", "citedby": "87"}, {"bib": {"title": "Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability?", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:O3NaXMp0MMsC", "citedby": "85"}, {"bib": {"title": "Keratin\u201018 and micro RNA\u2010122 complement alanine aminotransferase as novel safety biomarkers for drug\u2010induced liver injury in two human cohorts", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tOudhMTPpwUC", "citedby": "83"}, {"bib": {"title": "Drug\u2010induced liver injury: advances in mechanistic understanding that will inform risk management", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:7Hz3ACDFbsoC", "citedby": "80"}, {"bib": {"title": "Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:vV6vV6tmYwMC", "citedby": "80"}, {"bib": {"title": "COMT inhibitors and liver toxicity.", "year": "2000"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:CaZNVDsoPx4C", "citedby": "80"}, {"bib": {"title": "Are patients with elevated liver tests at increased risk of drug-induced liver injury?", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:pqnbT2bcN3wC", "citedby": "79"}, {"bib": {"title": "In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym\u2122: a mechanistic, mathematical model of DILI", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:dshw04ExmUIC", "citedby": "77"}, {"bib": {"title": "Tolcapone: an efficacy and safety review (2007)", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ZHo1McVdvXMC", "citedby": "76"}, {"bib": {"title": "The application of metabonomics to predict drug\u2010induced liver injury", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:a0OBvERweLwC", "citedby": "74"}, {"bib": {"title": "Serum proteomic profiling in patients with drug\u2010induced liver injury", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:abG-DnoFyZgC", "citedby": "73"}, {"bib": {"title": "Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:yD5IFk8b50cC", "citedby": "72"}, {"bib": {"title": "Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats.", "year": "1987"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ldfaerwXgEUC", "citedby": "72"}, {"bib": {"title": "An analysis of N-acetylcysteine treatment for acetaminophen overdose using a systems model of drug-induced liver injury", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:1sJd4Hv_s6UC", "citedby": "70"}, {"bib": {"title": "Biomarkers for the diagnosis and management of drug-induced liver injury", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_xSYboBqXhAC", "citedby": "70"}, {"bib": {"title": "Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:zA6iFVUQeVQC", "citedby": "70"}, {"bib": {"title": "Steady\u2010state pharmacokinetics of delavirdine in HIV\u2010positive patients: effect on erythromycin breath test", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:g5m5HwL7SMYC", "citedby": "69"}, {"bib": {"title": "Incidence and etiology of drug-induced liver injury in Mainland China", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:pS0ncopqnHgC", "citedby": "68"}, {"bib": {"title": "Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical", "year": "1998"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:M05iB0D1s5AC", "citedby": "67"}, {"bib": {"title": "Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:35N4QoGY0k4C", "citedby": "67"}, {"bib": {"title": "FutureTox II: In vitro Data and In Silico Models for Predictive Toxicology", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tzM49s52ZIMC", "citedby": "66"}, {"bib": {"title": "Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:olpn-zPbct0C", "citedby": "66"}, {"bib": {"title": "Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:f2IySw72cVMC", "citedby": "66"}, {"bib": {"title": "Induction of digitoxigenin monodigitoxoside UDP-glucuronosyltransferase activity by glucocorticoids and other inducers of cytochrome P-450p in primary monolayer cultures of \u2026", "year": "1986"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:SeFeTyx0c_EC", "citedby": "66"}, {"bib": {"title": "Candidate biomarkers for the diagnosis and prognosis of drug\u2010induced liver injury: An international collaborative effort", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Dem6FJhTUoYC", "citedby": "65"}, {"bib": {"title": "Systems pharmacology modeling predicts delayed presentation and species differences in bile acid\u2013mediated troglitazone hepatotoxicity", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:PR6Y55bgFSsC", "citedby": "64"}, {"bib": {"title": "Cytochrome P450 3A4 and P\u2010glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HoB7MX3m0LUC", "citedby": "61"}, {"bib": {"title": "Effects of a prolonged standardized diet on normalizing the human metabolome", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:EUQCXRtRnyEC", "citedby": "60"}, {"bib": {"title": "Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:B3FOqHPlNUQC", "citedby": "59"}, {"bib": {"title": "Minocycline hepatotoxicity: clinical characterization and identification of HLA-B\u2217 35: 02 as a risk factor", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NyGDZy8z5eUC", "citedby": "58"}, {"bib": {"title": "Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:UHK10RUVsp4C", "citedby": "58"}, {"bib": {"title": "Current challenges and controversies in drug-induced liver injury", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:UxriW0iASnsC", "citedby": "58"}, {"bib": {"title": "Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:5qfkUJPXOUwC", "citedby": "57"}, {"bib": {"title": "P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:3s1wT3WcHBgC", "citedby": "55"}, {"bib": {"title": "Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:AvfA0Oy_GE0C", "citedby": "54"}, {"bib": {"title": "Modeling drug-and chemical-induced hepatotoxicity with systems biology approaches", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:08ZZubdj9fEC", "citedby": "54"}, {"bib": {"title": "Identification of a novel route of extraction of sirolimus in human small intestine: roles of metabolism and secretion", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4OULZ7Gr8RgC", "citedby": "54"}, {"bib": {"title": "Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous \u2026", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:cFHS6HbyZ2cC", "citedby": "54"}, {"bib": {"title": "Parvovirus B19 outbreak on an adult ward", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:SnGPuo6Feq8C", "citedby": "54"}, {"bib": {"title": "Comparative analysis of portal hepatic infiltrating leucocytes in acute drug\u2010induced liver injury, idiopathic autoimmune and viral hepatitis", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:N5tVd3kTz84C", "citedby": "51"}, {"bib": {"title": "A mouse diversity panel approach reveals the potential for clinical kidney injury due to DB289 not predicted by classical rodent models", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:8AbLer7MMksC", "citedby": "51"}, {"bib": {"title": "Selective expression of CYP3A5 and not CYP3A4 in human blood.", "year": "1996"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:fPk4N6BV_jEC", "citedby": "51"}, {"bib": {"title": "Linking physiology to toxicity using DILIsym\u00ae, a mechanistic mathematical model of drug\u2010induced liver injury", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HE397vMXCloC", "citedby": "50"}, {"bib": {"title": "Application of a mechanistic model to evaluate putative mechanisms of tolvaptan drug-induced liver injury and identify patient susceptibility factors", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:cK4Rrx0J3m0C", "citedby": "46"}, {"bib": {"title": "Subtoxic alterations in hepatocyte-derived exosomes: an early step in drug-induced liver injury?", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:jL-93Qbq4QoC", "citedby": "46"}, {"bib": {"title": "Clinical pattern of zileuton-associated liver injury", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:CHSYGLWDkRkC", "citedby": "46"}, {"bib": {"title": "The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NhqRSupF_l8C", "citedby": "45"}, {"bib": {"title": "Predicting drug interactions in vivo from experiments in vitro: human studies with paclitaxel and ketoconazole", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:pyW8ca7W8N0C", "citedby": "45"}, {"bib": {"title": "Elucidating differences in the hepatotoxic potential of tolcapone and entacapone with DILIsym\u00ae, a mechanistic model of drug\u2010induced liver injury", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tH6gc1N1XXoC", "citedby": "43"}, {"bib": {"title": "Aflatoxin B1-adduct formation in rat and human small bowel enterocytes", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:xtRiw3GOFMkC", "citedby": "39"}, {"bib": {"title": "The transformation in biomarker detection and management of drug\u2010induced liver injury", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:-mN3Mh-tlDkC", "citedby": "38"}, {"bib": {"title": "Under-reporting and poor adherence to monitoring guidelines for severe cases of isoniazid hepatotoxicity", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:MAUkC_7iAq8C", "citedby": "38"}, {"bib": {"title": "Causality assessment for suspected DILI during clinical phases of drug development", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:LjlpjdlvIbIC", "citedby": "38"}, {"bib": {"title": "Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:mKu_rENv82IC", "citedby": "38"}, {"bib": {"title": "Distribution of cytochromes P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase in an entire human liver", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:b0M2c_1WBrUC", "citedby": "38"}, {"bib": {"title": "A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:VL0QpB8kHFEC", "citedby": "35"}, {"bib": {"title": "A mechanistic model of drug\u2010induced liver injury AIDS the interpretation of elevated liver transaminase levels in a phase I clinical trial", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:AXPGKjj_ei8C", "citedby": "35"}, {"bib": {"title": "Insight into hepatotoxicity: the troglitazone experience", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:nb7KW1ujOQ8C", "citedby": "35"}, {"bib": {"title": "Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:V3AGJWp-ZtQC", "citedby": "34"}, {"bib": {"title": "Pharmacogenetics in clinical pharmacology and toxicology", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:artPoR2Yc-kC", "citedby": "34"}, {"bib": {"title": "Cultured adult rat jejunal explants as a model for studying regulation of CYP3A", "year": "1993"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:OU6Ihb5iCvQC", "citedby": "34"}, {"bib": {"title": "The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:PaBasH6fAo0C", "citedby": "33"}, {"bib": {"title": "Editor\u2019s highlight: Candidate risk factors and mechanisms for tolvaptan-induced liver injury are identified using a collaborative cross approach", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WHdLCjDvYFkC", "citedby": "32"}, {"bib": {"title": "Mechanistic modeling reveals the critical knowledge gaps in bile acid\u2013mediated DILI", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tKAzc9rXhukC", "citedby": "32"}, {"bib": {"title": "Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:VOx2b1Wkg3QC", "citedby": "32"}, {"bib": {"title": "PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:uWQEDVKXjbEC", "citedby": "32"}, {"bib": {"title": "New insights into drug absorption: studies with sirolimus", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:XiSMed-E-HIC", "citedby": "31"}, {"bib": {"title": "Lack of susceptibility of the cottontop tamarin to hepatitis C infection", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:RoXSNcbkSzsC", "citedby": "31"}, {"bib": {"title": "Cyclosporine and liver transplantation: will the midazolam test make blood level monitoring obsolete?", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:P5F9QuxV20EC", "citedby": "31"}, {"bib": {"title": "Descending paralysis resulting from occult wound botulism", "year": "1984"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:fbc8zXXH2BUC", "citedby": "31"}, {"bib": {"title": "Role of cytochrome P450 phenotyping in cancer treatment", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:738O_yMBCRsC", "citedby": "30"}, {"bib": {"title": "Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease", "year": "1998"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:KxtntwgDAa4C", "citedby": "30"}, {"bib": {"title": "Low biotinidase activities in the sera of patients with impaired liver function: evidence that the liver is the source of serum biotinidase", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:nVrZBo8bIpAC", "citedby": "30"}, {"bib": {"title": "Sandwich-cultured hepatocytes as a tool to study drug disposition and drug-induced liver injury", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Ak0FvsSvgGUC", "citedby": "29"}, {"bib": {"title": "CYP3A probes can quantitatively predict the in vivo kinetics of other CYP3A substrates and can accurately assess CYP3A induction and inhibition", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:p2g8aNsByqUC", "citedby": "29"}, {"bib": {"title": "Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:35r97b3x0nAC", "citedby": "28"}, {"bib": {"title": "Pharmacogenetics and clinical gastroenterology", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tS2w5q8j5-wC", "citedby": "28"}, {"bib": {"title": "Erythromycin breath test and clinical transplantation", "year": "1996"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:SP6oXDckpogC", "citedby": "28"}, {"bib": {"title": "Use of a systems model of drug-induced liver injury (DILIsym\u00ae) to elucidate the mechanistic differences between acetaminophen and its less-toxic isomer, AMAP, in mice", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ZfRJV9d4-WMC", "citedby": "27"}, {"bib": {"title": "Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Tiz5es2fbqcC", "citedby": "26"}, {"bib": {"title": "Response to influenza virus vaccination in vertical HIV infection", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:65Yg0jNCQDAC", "citedby": "26"}, {"bib": {"title": "A missense variant in PTPN22 is a risk factor for drug-induced liver injury", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:eO3_k5sD8BwC", "citedby": "25"}, {"bib": {"title": "Beyond miR-122: identification of MicroRNA alterations in blood during a time course of hepatobiliary injury and biliary hyperplasia in rats", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ZzlSgRqYykMC", "citedby": "25"}, {"bib": {"title": "Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor \u2026", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ye4kPcJQO24C", "citedby": "25"}, {"bib": {"title": "Profiles of mi RNA s in serum in severe acute drug induced liver injury and their prognostic significance", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:MpfHP-DdYjUC", "citedby": "24"}, {"bib": {"title": "Elevated levels of circulating CDH5 and FABP1 in association with human drug\u2010induced liver injury", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ubry08Y2EpUC", "citedby": "24"}, {"bib": {"title": "Methodology to assess clinical liver safety data", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_Ybze24A_UAC", "citedby": "23"}, {"bib": {"title": "Degradation of the hepatic cytochromes P-450", "year": "1987"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WbkHhVStYXYC", "citedby": "23"}, {"bib": {"title": "Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:t7zJ5fGR-2UC", "citedby": "22"}, {"bib": {"title": "The Environmental Polymorphisms Registry: a DNA resource to study genetic susceptibility loci", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:mvPsJ3kp5DgC", "citedby": "22"}, {"bib": {"title": "Detection of acetaminophen protein adducts in serum during therapeutic dosing of acetaminophen in healthy volunteers", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:vRqMK49ujn8C", "citedby": "22"}, {"bib": {"title": "The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity", "year": "1996"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:u9iWguZQMMsC", "citedby": "22"}, {"bib": {"title": "Safety biomarkers for drug-induced liver injury\u2013current status and future perspectives", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:eq2jaN3J8jMC", "citedby": "21"}, {"bib": {"title": "Erythromycin breath test", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:l7t_Zn2s7bgC", "citedby": "21"}, {"bib": {"title": "INTERINDIVIDUAL VARIATION IN INTESTINAL MDR1 EXPRESSION-LACK OF SHORT-TERM DIET EFFECTS", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4fKUyHm3Qg0C", "citedby": "21"}, {"bib": {"title": "Fatal hepatic necrosis associated with parenteral gold therapy", "year": "1988"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:sSrBHYA8nusC", "citedby": "21"}, {"bib": {"title": "Refining liver safety risk assessment: application of mechanistic modeling and serum biomarkers to cimaglermin alfa (GGF2) clinical trials", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:yxmsSjX2EkcC", "citedby": "20"}, {"bib": {"title": "MITOsym\u00ae: a mechanistic, mathematical model of hepatocellular respiration and bioenergetics", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:p__nRnzSRKYC", "citedby": "20"}, {"bib": {"title": "Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:u-coK7KVo8oC", "citedby": "20"}, {"bib": {"title": "miR-122 release in exosomes precedes overt tolvaptan-induced necrosis in a primary human hepatocyte micropatterned coculture model", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:SjuI4pbJlxcC", "citedby": "19"}, {"bib": {"title": "Systems pharmacology modeling of drug\u2010induced hyperbilirubinemia: differentiating hepatotoxicity and inhibition of enzymes/transporters", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kw52XkFRtyQC", "citedby": "19"}, {"bib": {"title": "Liver safety assessment in special populations (hepatitis B, C, and oncology trials)", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Mojj43d5GZwC", "citedby": "19"}, {"bib": {"title": "The new revolution in toxicology: the good, the bad, and the ugly", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:XiVPGOgt02cC", "citedby": "19"}, {"bib": {"title": "Toxicogenomics: transcription profiling for toxicology assessment", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:D_sINldO8mEC", "citedby": "19"}, {"bib": {"title": "Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:5Ul4iDaHHb8C", "citedby": "19"}, {"bib": {"title": "The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the future", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:PELIpwtuRlgC", "citedby": "18"}, {"bib": {"title": "Is quinine a suitable probe to assess the hepatic drug\u2010metabolizing enzyme CYP3A4?", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:geHnlv5EZngC", "citedby": "18"}, {"bib": {"title": "Can bile salt export pump inhibition testing in drug discovery and development reduce liver injury risk? An international transporter consortium perspective", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:3bvyWxjaHKcC", "citedby": "17"}, {"bib": {"title": "MicroRNA-34c-3p is an early predictive biomarker for doxorubicin-induced glomerular injury progression in male Sprague-Dawley rats", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:g3aElNc5_aQC", "citedby": "16"}, {"bib": {"title": "Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:SdhP9T11ey4C", "citedby": "16"}, {"bib": {"title": "Genetic predisposition to drug-induced liver disease.", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:fQNAKQ3IYiAC", "citedby": "16"}, {"bib": {"title": "[50] Breath tests as noninvasive assays of P450s", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:LPZeul_q3PIC", "citedby": "16"}, {"bib": {"title": "The DILI\u2010sim initiative: insights into hepatotoxicity mechanisms and biomarker interpretation", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:UuEBAcK4md4C", "citedby": "15"}, {"bib": {"title": "Bioprinted liver provides early insight into the role of Kupffer cells in TGF-\u03b21 and methotrexate-induced fibrogenesis", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:DkZNVXde3BIC", "citedby": "15"}, {"bib": {"title": "The role of cytochrome P450s in drug-induced liver disease", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:eJXPG6dFmWUC", "citedby": "15"}, {"bib": {"title": "Relapsing polychondritis and erythema elevatum diutinum: an unusual association refractory to dapsone.", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:KaMxkj08jr0C", "citedby": "15"}, {"bib": {"title": "Induction of MDR1 expression in normal rat and human intestine in vivo.", "year": "1996"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:BrmTIyaxlBUC", "citedby": "15"}, {"bib": {"title": "Decreased treatment time due to changes in technique and practice philosophy", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:1qzjygNMrQYC", "citedby": "15"}, {"bib": {"title": "Liver safety of fasiglifam (TAK-875) in patients with type 2 diabetes: review of the global clinical trial experience", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:QyXJ3EUuO1IC", "citedby": "14"}, {"bib": {"title": "Clopidogrel nonresponders discovered during point-of-care platelet aggregation testing", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:eflP2zaiRacC", "citedby": "14"}, {"bib": {"title": "Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875 \u2026", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:-nhnvRiOwuoC", "citedby": "13"}, {"bib": {"title": "Mechanistic modelling of drug-induced liver injury: investigating the role of innate immune responses", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hsZV8lGYWTMC", "citedby": "13"}, {"bib": {"title": "How to diagnose and exclude drug-induced liver injury", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:r_AWSJRzSzQC", "citedby": "13"}, {"bib": {"title": "Anti-tuberculosis drug-induced liver injury in Shanghai: validation of Hy\u2019s Law", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:W5xh706n7nkC", "citedby": "13"}, {"bib": {"title": "Managing the risk of drug\u2010induced liver injury", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:5awf1xo2G04C", "citedby": "13"}, {"bib": {"title": "Stable isotope resolved metabolomics of primary human hepatocytes reveals a stressed phenotype", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:1yQoGdGgb4wC", "citedby": "13"}, {"bib": {"title": "Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:5ugPr518TE4C", "citedby": "13"}, {"bib": {"title": "Omeprazole and aryl hydrocarbon hydroxylases: should we be worried?", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:J-pR_7NvFogC", "citedby": "12"}, {"bib": {"title": "Differential regulation of liver P\u2010450III cytochromes in choline\u2010deficient rats: Implications for the erythromycin breath test as a parameter of liver function", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kRWSkSYxWN8C", "citedby": "12"}, {"bib": {"title": "Analyzing the mechanisms behind macrolide antibiotic-induced liver injury using quantitative systems toxicology modeling", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:rTD5ala9j4wC", "citedby": "11"}, {"bib": {"title": "Pilot study of rosiglitazone as an in vivo probe of paclitaxel exposure", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tkaPQYYpVKoC", "citedby": "11"}, {"bib": {"title": "Resuscitation skills", "year": "1985"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:j7_hQOaDUrUC", "citedby": "11"}, {"bib": {"title": "Shared genetic risk factors across carbamazepine\u2010induced hypersensitivity reactions", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:silx2ntsSuwC", "citedby": "10"}, {"bib": {"title": "In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:6_hjMsCP8ZoC", "citedby": "10"}, {"bib": {"title": "Effect of Oxygen Concentration on Viability and Metabolism in a Fluidized-Bed Bioartificial Liver Using 31P and 13C NMR Spectroscopy", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Fu2w8maKXqMC", "citedby": "10"}, {"bib": {"title": "Combination lopinavir and ritonavir alter exogenous and endogenous bile acid disposition in sandwich-cultured rat hepatocytes", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kzcrU_BdoSEC", "citedby": "10"}, {"bib": {"title": "Drug Induced Liver Injury Network (DILIN) Prospective Study: Initial Results: 375", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:wbdj-CoPYUoC", "citedby": "10"}, {"bib": {"title": "Short term effect of medications on CYP3A4 and P-glycoprotein expression in human intestinal mucosa", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:q3oQSFYPqjQC", "citedby": "10"}, {"bib": {"title": "Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:zdjWy_NXXwUC", "citedby": "9"}, {"bib": {"title": "Drug-induced liver injury", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:X9ykpCP0fEIC", "citedby": "9"}, {"bib": {"title": "Cytokine profiles in acute liver injury\u2014Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:BrOSOlqYqPUC", "citedby": "9"}, {"bib": {"title": "Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:5MTHONV0fEkC", "citedby": "9"}, {"bib": {"title": "HLA-A* 33: 01 is strongly associated with drug-induced liver injury (DILI) due to terbinafine and several other unrelated compounds", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:PVgj2kMGcgYC", "citedby": "9"}, {"bib": {"title": "Biomarkers for drug-induced liver injury", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:VLnqNzywnoUC", "citedby": "9"}, {"bib": {"title": "Drug-induced liver injury network", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:t6usbXjVLHcC", "citedby": "9"}, {"bib": {"title": "Tacrine and transaminases", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:dTyEYWd-f8wC", "citedby": "9"}, {"bib": {"title": "PULSATION FREQUENCY OF GROWTH-HORMONE MAY MEDIATE GENDER DIFFERENCES IN CYP3A ACTIVITY IN MAN", "year": "1993"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:bnK-pcrLprsC", "citedby": "9"}, {"bib": {"title": "Blood gene expression profiling of an early acetaminophen response", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:2tRrZ1ZAMYUC", "citedby": "8"}, {"bib": {"title": "Identification of identical transcript changes in liver and whole blood during acetaminophen toxicity", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hkOj_22Ku90C", "citedby": "8"}, {"bib": {"title": "Genetic susceptibility to drug-induced liver disease", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:9vf0nzSNQJEC", "citedby": "8"}, {"bib": {"title": "Method for determining function of a unique cytochrome P-450 activity", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:JQOojiI6XY0C", "citedby": "8"}, {"bib": {"title": "Antimicrosomal antibodies: What are they telling us?", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:eMMeJKvmdy0C", "citedby": "8"}, {"bib": {"title": "The role of HLA-A* 33: 01 in patients with cholestatic hepatitis attributed to terbinafine", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:w0F2JDEymm0C", "citedby": "7"}, {"bib": {"title": "Optimized methods to explore the mechanistic and biomarker potential of hepatocyte-derived exosomes in drug-induced liver injury", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:OBSaB-F7qqsC", "citedby": "7"}, {"bib": {"title": "Transient changes in hepatic physiology that alter bilirubin and bile acid transport may explain elevations in liver chemistries observed in clinical trials of GGF2 \u2026", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:rHJHxKgnXwkC", "citedby": "7"}, {"bib": {"title": "Incidence and management of hepatic toxicity in pazopanib-treated patients", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:JoZmwDi-zQgC", "citedby": "7"}, {"bib": {"title": "Progress in our understanding of severe drug-induced liver injury.", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Y5dfb0dijaUC", "citedby": "7"}, {"bib": {"title": "Hepatology Highlights Hepatology highlights (p 227-228)", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:8Xgff_V0N9gC", "citedby": "7"}, {"bib": {"title": "Did this drug cause my patient's hepatitis?/In response", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:uLbwQdceFCQC", "citedby": "7"}, {"bib": {"title": "Hepatitis A virus infection. Should susceptible homosexual men be offered immunization.", "year": "1993"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:DrR-2ekChdkC", "citedby": "7"}, {"bib": {"title": "Mechanism-Based Markers of Drug-Induced Liver Injury to Improve the Physiological Relevance and Predictivity of In Vitro Models", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:q3CdL3IzO_QC", "citedby": "6"}, {"bib": {"title": "Biomarkers for drug-induced liver injury", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:IsPWOBWtZBwC", "citedby": "6"}, {"bib": {"title": "Erythromycin breath test.", "year": "2000"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:FiytvqdAVhgC", "citedby": "6"}, {"bib": {"title": "Ethanol increases risk of acetaminophen hepatotoxicity in healthy adults.", "year": "1998"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:dQ2og3OwTAUC", "citedby": "6"}, {"bib": {"title": "The cytochromes P-450", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:lvd772isFD0C", "citedby": "6"}, {"bib": {"title": "P-450III METABOLIZES CYCLOSPORINE A IN INTESTINAL-MUCOSA-OBSERVATIONS IN A NOVEL RAT MODEL", "year": "1989"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_B80troHkn4C", "citedby": "6"}, {"bib": {"title": "IDENTIFICATION OF A HUMAN CYTOCHROME-P-450 ISOZYME INDUCIBLE BY GLUCOCORTICOIDS AND MACROLIDE ANTIBIOTICS", "year": "1985"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ZuybSZzF8UAC", "citedby": "6"}, {"bib": {"title": "Hepatocyte-derived exosomes promote liver immune tolerance: Possible implications for idiosyncratic drug-induced liver injury", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:UmS_249rOGwC", "citedby": "5"}, {"bib": {"title": "Serum biomarkers of drug\u2010induced liver injury: Current status and future directions", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:An6A6Jpfc1oC", "citedby": "5"}, {"bib": {"title": "Prediction of safety margin and optimization of dosing protocol for a novel antibiotic using quantitative systems pharmacology modeling", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:-95Q15plzcUC", "citedby": "5"}, {"bib": {"title": "Dose-response in a high density three-dimensional liver device with real-time bioenergetic and metabolic flux quantification", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WC9gN4BGCRcC", "citedby": "5"}, {"bib": {"title": "Development of quantitative systems pharmacology and toxicology models within consortia: experiences and lessons learned through DILIsym development", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Br1UauaknNIC", "citedby": "5"}, {"bib": {"title": "Drug-Induced Liver Disease", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:wMgC3FpKEyYC", "citedby": "5"}, {"bib": {"title": "Association of CYP3A5* 3,* 6, and* 7 polymorphisms with hypertension", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WqliGbK-hY8C", "citedby": "5"}, {"bib": {"title": "Predicting drug interactions using cultured human hepatocytes", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:uJ-U7cs_P_0C", "citedby": "5"}, {"bib": {"title": "P-450IIIA phenotype accocunts ofr interpatient variation in cyclosporin A blood levels", "year": "1989"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:7T2F9Uy0os0C", "citedby": "5"}, {"bib": {"title": "Using quantitative systems toxicology to investigate observed species differences in CKA-mediated hepatotoxicity", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:VN7nJs4JPk0C", "citedby": "4"}, {"bib": {"title": "Metabolic barrier of the gastrointestinal tract", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:jFemdcug13IC", "citedby": "4"}, {"bib": {"title": "Investigation of isoniazid DILI mechanisms in human induced pluripotent stem cell derived hepatocytes", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:KUbvn5osdkgC", "citedby": "4"}, {"bib": {"title": "Subject race and liver biochemical profile are strongly associated with clinical outcomes and chronic liver injury: Results from the DILIN Prospective study: 837", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hMsQuOkrut0C", "citedby": "4"}, {"bib": {"title": "Common POLG genetic variants increase the risk of sodium valproate induced liver injury and failure", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NJ774b8OgUMC", "citedby": "4"}, {"bib": {"title": "Biomarkers of acute idiosyncratic hepatocellular injury (AIHI) within clinical trials", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:0KyAp5RtaNEC", "citedby": "4"}, {"bib": {"title": "CAR unlikely to significantly modulate acetaminophen hepatotoxicity in most humans", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:nrtMV_XWKgEC", "citedby": "4"}, {"bib": {"title": "Cell culture model for drug bioavailability", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_Re3VWB3Y0AC", "citedby": "4"}, {"bib": {"title": "Approaches to studying the role of transporters in drug interactions in man", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:evX43VCCuoAC", "citedby": "4"}, {"bib": {"title": "Omeprazole induction of cytochrome P\u2010450IA2: The importance of selecting the appropriate human model", "year": "1993"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:-_dYPAW6P2MC", "citedby": "4"}, {"bib": {"title": "Safety and Tolerability of Ubrogepant Following Intermittent, High Frequency Dosing (S17. 009)", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:27LrP4qxOz0C", "citedby": "3"}, {"bib": {"title": "Mechanistic modeling with DILIsym\u00ae predicts species differences in CKA via multiple hepatotoxicity mechanisms", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:L1USKYWJimsC", "citedby": "3"}, {"bib": {"title": "A genome-wide association study identifies potential susceptibility loci for hepatotoxicity due to various drugs", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ipzZ9siozwsC", "citedby": "3"}, {"bib": {"title": "African ancestry and higher prevalence of triple-negative breast cancer\ufeff", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hSRAE-fF4OAC", "citedby": "3"}, {"bib": {"title": "S1590 Immuno-Allergic (Ia) Manifestations of Drug-Induced Liver Injury (DILI) in the USA. Results from the Prospective Study of the DILI Network", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:epqYDVWIO7EC", "citedby": "3"}, {"bib": {"title": "Clinical advances in liver, pancreas, and biliary tract: causes, clinical features, and outcome from a prospective study of drug-induced liver injury in the United States", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:SAZ1SQo2q1kC", "citedby": "3"}, {"bib": {"title": "Lebertoxizit\u00e4t von Paracetamol", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:0izLItjtcgwC", "citedby": "3"}, {"bib": {"title": "Atorvastatin-Clopidogrel interaction-Response", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:zGdJYJv2LkUC", "citedby": "3"}, {"bib": {"title": "IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN NORMAL AND NEOPLASTIC KIDNEY AND URINARY-BLADDER EPITHELIUM", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:2KloaMYe4IUC", "citedby": "3"}, {"bib": {"title": "Nonuniform distribution of cytochrome P450IA2 in liver", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:zLWjf1WUPmwC", "citedby": "3"}, {"bib": {"title": "Identification of Candidate Risk Factor Genes for Human Idelalisib Toxicity Using a Collaborative Cross Approach", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:YlPif8NxrbYC", "citedby": "2"}, {"bib": {"title": "Safety and Tolerability of Ubrogepant Following Intermittent, High-Frequency Dosing", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:EsEWqaRxkBgC", "citedby": "2"}, {"bib": {"title": "Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug\u2010Induced Liver Injury", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:CYCckWUYoCcC", "citedby": "2"}, {"bib": {"title": "Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Xl6nMSl579sC", "citedby": "2"}, {"bib": {"title": "Role of vagal activation in postprandial glucose metabolism after gastric bypass in individuals with and without hypoglycaemia", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Hck25ST_3aIC", "citedby": "2"}, {"bib": {"title": "Advancing nonclinical innovation and safety in pharmaceutical testing", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:SGW5VrABaM0C", "citedby": "2"}, {"bib": {"title": "Mechanisms of Drug\u2010Induced Liver Injury", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:yB1At4FlUx8C", "citedby": "2"}, {"bib": {"title": "Prospective liver safety comparison of two treatments for autosomal-dominant polycystic kidney disease (ADPKD) using quantitative systems toxicology modeling", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NDuN12AVoxsC", "citedby": "2"}, {"bib": {"title": "Candidate liver safety biomarkers provide prognostic and mechanistic insights in patients with drug-induced liver injury", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:q-HalDI95KYC", "citedby": "2"}, {"bib": {"title": "Drug Metabolism, Transport, and Pharmacogenomics", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:gVv57TyPmFsC", "citedby": "2"}, {"bib": {"title": "MECHANISTIC MODELING WITH DILISYM\u00ae PREDICTS DOSE-DEPENDENT CLINICAL HEPATOTOXICITY OF AMG 009 THAT INVOLVES BILE ACID TRANSPORTER INHIBITION", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:uDGL6kOW6j0C", "citedby": "2"}, {"bib": {"title": "The dili-sim initiative. Integrated systems pharmacology modeling to explain and predict drug hepatotoxicity", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4hFrxpcac9AC", "citedby": "2"}, {"bib": {"title": "CHEMOKINE/CYTOKINE PROFILES IN PATIENTS WITH ACUTE DILI: RESULTS FROM THE US DRUG-INDUCED LIVER INJURY NETWORK: 342", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:BUYA1_V_uYcC", "citedby": "2"}, {"bib": {"title": "S1002 Co-Medication with Adrenoreceptor Antagonists Is Associated with Lower MELD Scores At Admission in Patients with Acetaminophen-Induced Acute Liver Failure", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tYavs44e6CUC", "citedby": "2"}, {"bib": {"title": "A furanocoumarin-free grapefruit juice does not alter the oral pharmacokinetics of felodipine", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:vbGhcppDl1QC", "citedby": "2"}, {"bib": {"title": "The effect of drugs which are known inducers and inhibitors of human cytochrome P450 3A on the platelet inhibitory activity of clopidogrel", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:fEOibwPWpKIC", "citedby": "2"}, {"bib": {"title": "The two major furocoumarins in grapefruit juice have distinct absorption and protein binding characteristics", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:9Nmd_mFXekcC", "citedby": "2"}, {"bib": {"title": "Pharmacokinetics and drug disposition: role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:isU91gLudPYC", "citedby": "2"}, {"bib": {"title": "INTERPATIENT HETEROGENEITY IN EXPRESSION OF CYP3A4 AND CYP3A5 IN SMALL-BOWEL-LACK OF PREDICTION BY THE ERYTHROMYCIN BREATH TEST (VOL 22, PG 947, 1994)", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:TlpoogIpr_IC", "citedby": "2"}, {"bib": {"title": "TACRINE HEPATOTOXICITY-THE USE OF CAFFEINE TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:uc_IGeMz5qoC", "citedby": "2"}, {"bib": {"title": "CYP3A5 expression in human enterocytes", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:XD-gHx7UXLsC", "citedby": "2"}, {"bib": {"title": "P450IIIA (CYP3A) activity in severely depressed patients.", "year": "1993"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:b1wdh0AR-JQC", "citedby": "2"}, {"bib": {"title": "CYCLOSPORINE IS METABOLIZED BY ENTEROCYTE P450IIIA INVIVO", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:9c2xU6iGI7YC", "citedby": "2"}, {"bib": {"title": "CYCLOSPORINE IS METABOLIZED INVIVO BY CYTOCHROME-P-450IIIA IN RAT JEJUNAL MUCOSA", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:URolC5Kub84C", "citedby": "2"}, {"bib": {"title": "Quantitative systems toxicology (QST) reproduces species differences in PF\u201004895162 liver safety due to combined mitochondrial and bile acid toxicity", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:wE-fMHVdjMkC", "citedby": "1"}, {"bib": {"title": "A Rapid Method to Estimate Hepatocyte Loss Due to Drug\u2010Induced Liver Injury", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:w1MjKQ0l0TYC", "citedby": "1"}, {"bib": {"title": "New Biomarkers for Drug-Induced Liver Injury Reply", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:FiDNX6EVdGUC", "citedby": "1"}, {"bib": {"title": "Improving Interpretation of New and Old Serum Biomarkers of Drug\u2010Induced Liver Injury Through Mechanistic Modeling", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ce2CqMG-AY4C", "citedby": "1"}, {"bib": {"title": "An Introduction to DILIsym\u00ae Software, a Mechanistic Mathematical Representation of Drug-Induced Liver Injury", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:sszUF3NjhM4C", "citedby": "1"}, {"bib": {"title": "Amoxicillin/clavulanic acid/tolvaptan", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HGTzPopzzJcC", "citedby": "1"}, {"bib": {"title": "Detecting Drug-Induced Liver Injury in Patients with Decompensated Chronic Hepatitis C: A Review of the SOLAR-1 and SOLAR-2 Studies: 96", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:0CzhzZyukY4C", "citedby": "1"}, {"bib": {"title": "The Epidemiology of Suspected Drug Induced Liver Injury in the US: The Delaware Liver Injury Study: 1932", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:AHdEip9mkN0C", "citedby": "1"}, {"bib": {"title": "Cholestatic Drug reactions are more likely to cause persistent liver injury and impaired Quality of Life during prolonged follow-up: Results from the DILIN Prospective study: 1067", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NxmKEeNBbOMC", "citedby": "1"}, {"bib": {"title": "USING DILISYM\u00ae AND MITOSYM\u2122 TO INVESTIGATE IN VIVO ETOMOXIR-INDUCED DILI BASED ON IN VITRO DATA.: PII-010", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:8d8msizDQcsC", "citedby": "1"}, {"bib": {"title": "Cholestatic drug reactions are more likely to cause persistent liver injury and impaired quality of life during prolonged follow-up: results from the DILIN Prospective study", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ML0RJ9NH7IQC", "citedby": "1"}, {"bib": {"title": "Causative Agents, Clinical Features, and Outcomes of Idiosyncratic Drug Induced Liver Injury (DILI) in the Elderly: Results From the DILIN Prospective Study: ACG Governors \u2026", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:9pM33mqn1YgC", "citedby": "1"}, {"bib": {"title": "keynote lecture \u2018\u2018", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:1taIhTC69MYC", "citedby": "1"}, {"bib": {"title": "HISTOLOGIC ANALYSIS AND CORRELATION WITH CLINICAL OUTCOMES IN THE DRUG-INDUCED LIVER INJURY NETWORK (DILIN): 320", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:gsN89kCJA0AC", "citedby": "1"}, {"bib": {"title": "A Randomized, Double-Blind Study to Assess Serum Transaminase Elevations and Antibody Formation Following Repeat Subcutaneous Dosing of LMWH, UFH or the Novel Anticoagulant \u2026", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:DJbcl8HfkQkC", "citedby": "1"}, {"bib": {"title": "Drug metabolism and transport in the liver and intestine", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4MWp96NkSFoC", "citedby": "1"}, {"bib": {"title": "Characteristics of Patients with Idiosyncratic Drug Induced Liver Injury (DILI) Who Receive Systemic Corticosteroids: Initial Results from the US DILI Network Prospective Study \u2026", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:sNmaIFBj_lkC", "citedby": "1"}, {"bib": {"title": "Inhibitor potency of two furocoumarins toward CYP3A4 activity is substrate dependent in a whole cell system", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:BwyfMAYsbu0C", "citedby": "1"}, {"bib": {"title": "Effects of a chargrilled meat diet on human liver and intestinal CYP3A4 and CYP1A expression.", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ILKRHgRFtOwC", "citedby": "1"}, {"bib": {"title": "METABOLISM OF THE IMMUNOSUPPRESSANT FK506 IN THE SMALL-INTESTINE-P450, DRUG-INTERACTIONS AND INTERINDIVIDUAL VARIABILITY", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:mNrWkgRL2YcC", "citedby": "1"}, {"bib": {"title": "CYTOCHROME-P450 3A5 IS THE MAJOR 3A SUBFAMILY MEMBER EXPRESSED IN NORMAL HUMAN SKIN IN-VIVO", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:EkHepimYqZsC", "citedby": "1"}, {"bib": {"title": "INVIVO INHIBITION OF GLUCOCORTICOID-INDUCIBLE LIVER CYTOCHROMES P-450 IN RATS AND PATIENTS", "year": "1987"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:TIZ-Mc8IlK0C", "citedby": "1"}, {"bib": {"title": "IDENTIFICATION OF A DEXAMETHASONE INDUCIBLE ISOZYME OF CYTOCHROME-P450 IN RAT AND HUMAN INTESTINAL-MUCOSA", "year": "1985"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:EYYDruWGBe4C", "citedby": "1"}, {"bib": {"title": "IDENTIFICATION OF HOMOLOGS OF RAT-LIVER CYTOCHROME-P-450P IN OTHER SPECIES", "year": "1985"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Z5m8FVwuT1cC", "citedby": "1"}, {"bib": {"title": "DEGRADATION OF CYTOCHROME P-450DEX IS INHIBITED BY MACROLIDE ANTIBIOTICS IN PRIMARY MONOLAYER-CULTURES OF ADULT-RAT HEPATOCYTES", "year": "1984"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:L7CI7m0gUJcC", "citedby": "1"}, {"bib": {"title": "INHIBITION OF CYTOCHROME-P-450P DEGRADATION BY MACROLIDE ANTIBIOTICS IN HEPATOCYTE CULTURES IS NOT RELATED TO FORMATION OF METABOLITE-HEME COMPLEXES", "year": "1984"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:vDijr-p_gm4C", "citedby": "1"}, {"bib": {"title": "Drug Metabolism and Disposition"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:prdVHNxh-e8C", "citedby": "1"}, {"bib": {"title": "Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables", "year": "2020"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:KWzIFqRkAKkC", "citedby": "0"}, {"bib": {"title": "HLA\u2010B* 14: 01 and HLA\u2010B* 35: 01 are associated with trimethoprim\u2010sulfamethoxazole induced liver injury", "year": "2020"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:-uzm3Y7AvW0C", "citedby": "0"}, {"bib": {"title": "Rivaroxaban Precision Dosing Strategy for Real World Atrial Fibrillation Patients", "year": "2020"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:JP7YXuLIOvAC", "citedby": "0"}, {"bib": {"title": "Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury", "year": "2020"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ZqE1mSdD_DYC", "citedby": "0"}, {"bib": {"title": "HLA associations with infliximab-induced liver injury", "year": "2020"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NMlhSUseqAsC", "citedby": "0"}, {"bib": {"title": "Quantitative Systems Toxicology Approaches to Understand and Predict Drug-Induced Liver Injury", "year": "2020"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tHtfpZlB6tUC", "citedby": "0"}, {"bib": {"title": "Next\u2010Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development", "year": "2020"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:v6i8RKmR8ToC", "citedby": "0"}, {"bib": {"title": "Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:1tZ8xJnm2c8C", "citedby": "0"}, {"bib": {"title": "Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics: Miniperspective", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:unp9ATQDT5gC", "citedby": "0"}, {"bib": {"title": "MECHANISTIC MODELING AIDS IN THE INTERPRETATION OF ALANINE AMINOTRANSFERASE ELEVATIONS ASSOCIATED WITH CLINICAL ISCHEMIC LIVER INJURY", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:qE4H1tSSYIIC", "citedby": "0"}, {"bib": {"title": "DISCOVERY OF ERAP2 GENE EXPRESSION AS A RISK FACTOR FOR DRUG-INDUCED LIVER INJURY DUE TO AMOXICILLIN-CLAVULANIC ACID.", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:C33y2ycGS3YC", "citedby": "0"}, {"bib": {"title": "Novel Mechanisms of Valproate Hepatotoxicity: Impaired Mrp2 Trafficking and Hepatocyte Depolarization", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:-DxkuPiZhfEC", "citedby": "0"}, {"bib": {"title": "Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implications.", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:sA9dB-pw3HoC", "citedby": "0"}, {"bib": {"title": "HLA B* 14: 01 is associated with Trimethoprim-sulfamethoxazole induced liver injury", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:SIv7DqKytYAC", "citedby": "0"}, {"bib": {"title": "Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group (vol 13, e0206389, 2018)", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:2v_ZtQDX9iAC", "citedby": "0"}, {"bib": {"title": "Correction: Cytokine profiles in acute liver injury\u2014Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:wvYxNZNCP7wC", "citedby": "0"}, {"bib": {"title": "Transient Aminotransferase Increases Following Acetaminophen Treatment in Rats", "year": "2019"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:k_7cPK9k7w8C", "citedby": "0"}, {"bib": {"title": "Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:2l5NCbZemmgC", "citedby": "0"}, {"bib": {"title": "Zonal Hepatic Stellate Cell (HSC) Activation in Nonalcoholic Steatohepatitis (NASH) Characterized By a Mathematical Model", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kzcSZmkxUKAC", "citedby": "0"}, {"bib": {"title": "Identification of Exosomal Valosin Containing Protein (VCP) As a Potential Biomarker of Idiosyncratic Drug-Induced Liver Injury", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kF1pexMAQbMC", "citedby": "0"}, {"bib": {"title": "Using Quantitative Systems Pharmacology Modeling to Understand the Effects of Acetyl CoA Carboxylase (ACC) Inhibition on Liver and Plasma Triglycerides in a Simulated Population", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:raTqNPD5sRQC", "citedby": "0"}, {"bib": {"title": "Quantitative Systems Toxicology (QST) Supports Differentiated Liver Safety for a Next-in-Class Compound", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:YsrPvlHIBpEC", "citedby": "0"}, {"bib": {"title": "Quantitative Systems Toxicology Modeling Using DILIsym Suggests That Mitochondrial Biogenesis Could Explain Adaptation to Drug-Induced Liver Injury (DILI)", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ziOE8S1-AIUC", "citedby": "0"}, {"bib": {"title": "Zonal Extracellular Matrix (ECM) Accumulation in Nonalcoholic Steatohepatitis (NASH) Characterized by a Mathematical Model of Fibrosis", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:mUJArPsKIAAC", "citedby": "0"}, {"bib": {"title": "Development of a New Serum ALT Profile Parameter to Predict Hepatocyte Loss in Drug Induced Liver Injury using Systems Pharmaco-Toxicology Approach", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:oi2SiIJ9l4AC", "citedby": "0"}, {"bib": {"title": "Identification of a PTPN22 Missense Variant As a General Genetic Risk Factor for Drug-Induced Liver Injury", "year": "2018"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WAzi4Gm8nLoC", "citedby": "0"}, {"bib": {"title": "Quantitative systems toxicology analysis of in vitro mechanistic assays reveals importance of bile acid accumulation in TAK-875-induced liver injury", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:1Ye0OR6EYb4C", "citedby": "0"}, {"bib": {"title": "Serum MicroRNA-122 Levels Are Highly Variable in a Cohort of Healthy Volunteers", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:AXkvAH5U_nMC", "citedby": "0"}, {"bib": {"title": "Modeling compound-induced hepatic fibrosis in vitro using three-dimensional liver tissue constructs", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:DBa1UEJaJKAC", "citedby": "0"}, {"bib": {"title": "Looking to the future of drug-induced liver injury: an interview with Paul B Watkins", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Ade32sEp0pkC", "citedby": "0"}, {"bib": {"title": "Understanding hepatoxicity: Man to mouse to computer", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kWvqk_afx_IC", "citedby": "0"}, {"bib": {"title": "QSP MODELING OF LIVER DGAT INHIBITION USING NAFLDSYM IS PREDICTED TO REDUCE STEATOSIS BUT MAY NOT RELIEVE LIPOTOXICITY IN NAFLD PATIENTS", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:PYBJJbyH-FwC", "citedby": "0"}, {"bib": {"title": "Using Systems Pharmacology Modeling to Understand the Pathophysiology of NAFLD and Response to Dietary Intervention in a Simulated Population", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:wKETBy42zhYC", "citedby": "0"}, {"bib": {"title": "QSP Modeling of Liver AMPK Activation Using NAFLDsym Is Predicted to Reduce Steatosis in NAFLD Patients", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:7H_MAutzIkAC", "citedby": "0"}, {"bib": {"title": "MECHANISTIC MODELING AND HEPATIC BIOMARKER DATA FROM GGF2 (CIMAGLERMIN ALFA)-TREATED SUBJECTS IN PHASE 1 CLINCIAL TRIALS SUGGEST LOW LIKELIHOOD OF PROGRESSIVE LIVER INJURY", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WC23djZS0W4C", "citedby": "0"}, {"bib": {"title": "Minocycline hepatotoxicity", "year": "2017"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:qe6vwMD2xtsC", "citedby": "0"}, {"bib": {"title": "Mathematical Modeling to Investigate Pleiotropic TNF-alpha Activity in Drug-Induced Liver Injury", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:XUvXOeBm_78C", "citedby": "0"}, {"bib": {"title": "Mechanistic modeling of drug-induced liver injury due to mtDNA depletion in DILIsym\u00ae", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:jU7OWUQzBzMC", "citedby": "0"}, {"bib": {"title": "Detecting DILI in Patients with Decompensated Chronic Hepatitis C: A Review of the SOLAR-1 and-2 Studies", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:43bX7VzcjpAC", "citedby": "0"}, {"bib": {"title": "Hepatic biomarkers and the transformation of liver risk assessment", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kVjdVfd2voEC", "citedby": "0"}, {"bib": {"title": "Understanding idiosyncratic hepatoxicity: from cage to clinic", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:v1_lew4L6wgC", "citedby": "0"}, {"bib": {"title": "Alterations in hepatocyte-derived exosomal rna are observed prior to overt injury in rat and human drug-induced liver injury models", "year": "2016"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:U4n9YNQMCAIC", "citedby": "0"}, {"bib": {"title": "SYSTEMS PHARMACOLOGY MODELING PREDICTS HEPATOTOXIC POTENTIAL OF TROGLITAZONE AND PIOGLITAZONE", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4X0JR2_MtJMC", "citedby": "0"}, {"bib": {"title": "PredictingIn VivoHepatotoxicity for a Pair of Related Compounds with a Mechanistic Model of Drug-induced Livery Injury: 224", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:6yz0xqPARnAC", "citedby": "0"}, {"bib": {"title": "Genome-wide investigation identifies common SNPs on Chr9p22. 2 as risk factors for liver injury due to sulfamethoxazole/trimethoprim: 1933", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:sJsF-0ZLhtgC", "citedby": "0"}, {"bib": {"title": "Quantitative Systems Modeling Provides Biological Plausibility for Potential Mechanisms of Tolvaptan-Induced Hepatotoxicity", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:F1b5ZUV5XREC", "citedby": "0"}, {"bib": {"title": "Lipotoxicity Accounts for Liver Injury due to Etomoxir: Application of Systems Toxicology Modeling of a Patient Population: 228", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:LgRImbQfgY4C", "citedby": "0"}, {"bib": {"title": "Mechanistic Modeling of Drug-Induced Liver Injury (DILI)", "year": "2015"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:8xutWZnSdmoC", "citedby": "0"}, {"bib": {"title": "Idiosyncratic Drug-Induced Liver Injury (DILI) in the United States: A Report of 1,257 Prospectively Enrolled Patients: ACG Governors Award for Excellence in Clinical Research: 450", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:hCrLmN-GePgC", "citedby": "0"}, {"bib": {"title": "INSIGHTS FROM HEALTHY VOLUNTEER STUDIES", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:OP4eGU-M3BUC", "citedby": "0"}, {"bib": {"title": "Detection of Xenobiotic-Induced Hepatotoxicity in Human iPSC-derived Hepatocytes", "year": "2014"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:oNZyr7d5Mn4C", "citedby": "0"}, {"bib": {"title": "Using the DILIsym (TM) and MITOsym (TM) mathematical models to predict in vivo mitochondria-based DILI based on in vitro screening data", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:ODE9OILHJdcC", "citedby": "0"}, {"bib": {"title": "Use of a Mechanistic Model of Drug-Induced Liver Injury (DILIsym (TM)) to Support Interpretation of Elevated Liver Transaminase Levels in a Healthy Volunteer Pooled Safety \u2026", "year": "2013"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:YohjEiUPhakC", "citedby": "0"}, {"bib": {"title": "Understanding hepatotoxicity\u2013from patients to mice to computer", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:umqufdRvDiIC", "citedby": "0"}, {"bib": {"title": "Whole-exome sequencing identifies rare genetic variants that may contribute to isoniazid (INH)-induced liver injury: 821", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Ri6SYOTghG4C", "citedby": "0"}, {"bib": {"title": "Computational prediction of liver toxicity using the DILIsym (TM) model", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:4fGpz3EwCPoC", "citedby": "0"}, {"bib": {"title": "Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:1DsIQWDZLl8C", "citedby": "0"}, {"bib": {"title": "Novel DILI biomarkers for prediction of acetaminophen-induced human hepatotoxicity", "year": "2012"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:OcBU2YAGkTUC", "citedby": "0"}, {"bib": {"title": "SERUM PROTEOMIC PROFILING IN PATIENTS WITH DRUG-INDUCED LIVER INJURY: 326", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:g5Ck-dwhA_QC", "citedby": "0"}, {"bib": {"title": "OPTIMIZING N-ACETYLCYSTEINE TREATMENT FOR ACETAMINOPHEN OVERDOSE USING A SYSTEMS MODEL OF DRUG-INDUCED LIVER INJURY: 317", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:cWzG1nlazyYC", "citedby": "0"}, {"bib": {"title": "SERUM INCREASES OF LIVER BIOMARKERS FOLLOWING HEPARIN TREATMENT IS DUE TO HEPATOCYTE NECROSIS: RESULTS OF A HEALTHY VOLUNTEER STUDY: 299", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:a9-T7VOCCH8C", "citedby": "0"}, {"bib": {"title": "SERUM PROTEOMIC PROFILING IN PATIENTS WITH DRUG-INDUCED LIVER INJURY", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Dip1O2bNi0gC", "citedby": "0"}, {"bib": {"title": "Idiosyncratic drug induced liver injury: From man to mouse to computer", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:XvxMoLDsR5gC", "citedby": "0"}, {"bib": {"title": "Liver-Specific mRNAs Are Present in Cell-Free Plasma in Man and May Serve as Novel Biomarkers for Drug-Induced Liver Injury", "year": "2011"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:xtoqd-5pKcoC", "citedby": "0"}, {"bib": {"title": "Understanding Idiosyncratic Hepatoxicity: From Man to Mouse to Computer", "year": "2010"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:P7Ujq4OLJYoC", "citedby": "0"}, {"bib": {"title": "An'Omics' Approach for Identifying Biomarkers of Adverse Effects", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:IUKN3-7HHlwC", "citedby": "0"}, {"bib": {"title": "Novel Approaches to Generate Biomarkers of Idiosyncratic Hepatotoxicity", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:NXb4pA-qfm4C", "citedby": "0"}, {"bib": {"title": "Association of Breast Cancer Resistance Protein/ABCG2 Phenotypes and Novel Promoter and Intron 1 Single Nucleotide Polymorphisms", "year": "2009"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:dBIO0h50nwkC", "citedby": "0"}, {"bib": {"title": "Dysregulation of intestinal CYP3A4-dependent 1, 25-dihydroxyvitamin D3 catabolism: a potential mechanism for drug-induced osteomalacia", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Ehil0879vHcC", "citedby": "0"}, {"bib": {"title": "Erratum: Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:AzKEL7Gb_04C", "citedby": "0"}, {"bib": {"title": "Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury This is publication# 1 from the Drug-Induced Liver Injury \u2026", "year": "2008"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:MhiOAD_qIWkC", "citedby": "0"}, {"bib": {"title": "B-Lymphocytes as an in-vitro model to study interindividual variation in sensitivity to acetaminophen toxicity", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:anf4URPfarAC", "citedby": "0"}, {"bib": {"title": "11 Genetic Susceptibility to Drug-Induced Liver Disease", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:mWEH9CqjF64C", "citedby": "0"}, {"bib": {"title": "11|| Genetic Susceptibility to Drug-Induced", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:FAceZFleit8C", "citedby": "0"}, {"bib": {"title": "PMC2117899.", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:A8cqit5AE6sC", "citedby": "0"}, {"bib": {"title": "A Q&A approach to drug-induced liver injury", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HtEfBTGE9r8C", "citedby": "0"}, {"bib": {"title": "METABOLISM, TRANSPORT, AND PHARMACOGENOMICS-Differential Inhibition of Rat and Human Na+-Dependent Taurocholate Cotransporting Polypeptide (NTCP/SLC10A1) by Bosentan: A \u2026", "year": "2007"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_FM0Bhl9EiAC", "citedby": "0"}, {"bib": {"title": "GENE EXPRESSION ANALYSIS OF PERIPHERAL BLOOD YIELDS SIGNS OF ACETAMINOPHEN EXPOSURE IN THE ABSENCE OF DETECTABLE LEVELS: 896", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:VaXvl8Fpj5cC", "citedby": "0"}, {"bib": {"title": "Elevation des transaminases chez des adultes sains recevant 4 grammes par jour d'acetaminophene: Un essai controle randomise", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:QYdC8u9Cj1oC", "citedby": "0"}, {"bib": {"title": "Increased ALT levels with paracetamol 4 g/day", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:edDO8Oi4QzsC", "citedby": "0"}, {"bib": {"title": "Influence of CYP3A5 genotype on the extent of CYP3A inhibition in healthy African-Americans", "year": "2006"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:MLfJN-KU85MC", "citedby": "0"}, {"bib": {"title": "Apparent oral clearance of saquinavir is predicted by CYP3A5* 1 genotype but not intestinal CYP3A5 expression: P108", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:BzfGm06jWhQC", "citedby": "0"}, {"bib": {"title": "Use and overuse of acetaminophen in patients on narcotic-acetaminophen combination medications", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HtS1dXgVpQUC", "citedby": "0"}, {"bib": {"title": "Does sex influence proximal small intestinal CYP3A or P\u2010GP expression?", "year": "2005"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:GtLg2Ama23sC", "citedby": "0"}, {"bib": {"title": "Interaction between CYP3A4 and Pgp during intestinal drug absorption", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:LO7wyVUgiFcC", "citedby": "0"}, {"bib": {"title": "Do furanocoumarins mediate the grapefruit juice-cyclosporine interaction in humans in vivo?", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:XoXfffV-tXoC", "citedby": "0"}, {"bib": {"title": "The human intestinal cytochrome P450\" pie\"", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:lmc2jWPfTJgC", "citedby": "0"}, {"bib": {"title": "Liver transplantation for drug induced liver injury in the United States.", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:PVjk1bu6vJQC", "citedby": "0"}, {"bib": {"title": "Mechanisms that regulate production of reactive oxygen species by cytochrome P450.", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:2ywjKiB__4kC", "citedby": "0"}, {"bib": {"title": "ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION-Contributions of CYP3A4, P-glycoprotein, and Serum Protein Binding to the Intestinal First-Pass Extraction of Saquinavir", "year": "2004"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WJVC3Jt7v1AC", "citedby": "0"}, {"bib": {"title": "Atorvastatin and the Ability of Clopidogrel to Inhibit Platelet Aggregation: Response", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:uVUOdF_882EC", "citedby": "0"}, {"bib": {"title": "EFAVIRENZ INDUIT SPECIFIQUEMENT LE CYP3A4 HEPATIQUE ET NON INTESTINAL: ETUDE CLINIQUE CHEZ 24 SUJETS", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:GFxP56DSvIMC", "citedby": "0"}, {"bib": {"title": "LA P-GLYCOPROTEINE ET NON LE CYP3A4 LIMITE L'ABSORPTION INTESTINALE DE SAQUINAVIR", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:OR75R8vi5nAC", "citedby": "0"}, {"bib": {"title": "HEPATOLOGY, Vol. 38, No. 4, Suppl. 1, 2003 AASLD PROGRAM 33A", "year": "2003"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:foquWX3nUaYC", "citedby": "0"}, {"bib": {"title": "Une meilleure connaissance de l'absorption intestinale et du m\u00e9tabolisme h\u00e9patique des antiviraux permet d'optimiser la prescription au cours de l'infection par le VIH", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:FPJr55Dyh1AC", "citedby": "0"}, {"bib": {"title": "ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION-Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:LhH-TYMQEocC", "citedby": "0"}, {"bib": {"title": "PHARMACOKINETICS AND DRUG DISPOSITION-Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:bKqednn6t2AC", "citedby": "0"}, {"bib": {"title": "Correlation of cytochrome P450 3A5 genotype with measures of blood pressure and cardiovascular risk predictors", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:DUooU5lO8OsC", "citedby": "0"}, {"bib": {"title": "Efavirenz induit sp\u00e9cifiquement le CYP3A4 h\u00e9patique et non intestinal. \u00c9tude clinique chez 24 sujets", "year": "2002"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:Ug5p-4gJ2f0C", "citedby": "0"}, {"bib": {"title": "ASSESSMENT OF CYP3A4 AND P-GLYCOPROTEIN IN VIVO", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:qwy9JoKyICEC", "citedby": "0"}, {"bib": {"title": "QUININE AS AN IN VIVO PROBE FOR HUMAN CYP3A4", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:7BrZ7Jt4UNcC", "citedby": "0"}, {"bib": {"title": "PHARMACOKINETICS AND DRUG DISPOSITION-Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins", "year": "2001"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:IRz6iEL74y4C", "citedby": "0"}, {"bib": {"title": "LETTERS TO THE EDITOR-Erythromycin breath test", "year": "2000"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HJSXoJQnj-YC", "citedby": "0"}, {"bib": {"title": "Purification and characterization of six cytochrome P-450 isozymes from human livermicrosomes.", "year": "2000"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:pAkWuXOU-OoC", "citedby": "0"}, {"bib": {"title": "Impaired cytochrome P450 activity after surgery requiring cardiopulmonary bypass", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:F9fV5C73w3QC", "citedby": "0"}, {"bib": {"title": "PHARMACOKINETICS AND DRUG DISPOSITION-6', 7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P \u2026", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:yMeIxYmEMEAC", "citedby": "0"}, {"bib": {"title": "1999 ASPET OTTO KRAYER AWARD LECTURE-First-Pass Midazolam Metabolism Catalyzed by 1a, 25-Dihydroxy Vitamin D3-Modified Caco-2 Cell Monolayers", "year": "1999"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:3htObqc8RwsC", "citedby": "0"}, {"bib": {"title": "Unique expression patterns of the human UDP-glucuronosyltransferases in hepatic and extrahepatic tissues.", "year": "1998"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:tuHXwOkdijsC", "citedby": "0"}, {"bib": {"title": "Troglitazone-induced liver injury", "year": "1998"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:fFSKOagxvKUC", "citedby": "0"}, {"bib": {"title": "Grapefruit juice increases felodipine oral availability in man by decreasing intestinal CYP3A4 protein", "year": "1997"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_5tno0g5mFcC", "citedby": "0"}, {"bib": {"title": "Alanine aminotransferase elevations during zileuton therapy-Results of a large safety trial.", "year": "1996"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:bz8QjSJIRt4C", "citedby": "0"}, {"bib": {"title": "CYP3A5 and not CYP3A4 is present in peripheral blood.", "year": "1996"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:mlAyqtXpCwEC", "citedby": "0"}, {"bib": {"title": "Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter-and intraindividual hepatic CYP3A variability after liver transplantation: Thummel KE, Shen \u2026", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:6ZxmRoH8BuwC", "citedby": "0"}, {"bib": {"title": "IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN NORMAL AND NEOPLASTIC KIDNEY AND URINARY-BLADDER EPITHELIUM", "year": "1995"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:86PQX7AUzd4C", "citedby": "0"}, {"bib": {"title": "TACRINE HEPATOTOXICITY-THE USE OF METABOLIC PROBES TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:yqoGN6RLRZoC", "citedby": "0"}, {"bib": {"title": "ADVANCES IN THE MANAGEMENT OF ALZHEIMER-DISEASE-THE ROLE OF TACRINE-DISCUSSION", "year": "1994"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kh2fBNsKQNwC", "citedby": "0"}, {"bib": {"title": "Hepatitis A Virus Infection [with Reply]", "year": "1993"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:CNPyR2KL9-0C", "citedby": "0"}, {"bib": {"title": "THE ERYTHROMYCIN BREATH TEST PREDICTS ENTEROCYTE PHENOTYPE OF P450IIIA4 (CYP3A4) IN PATIENTS", "year": "1993"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:S16KYo8Pm5AC", "citedby": "0"}, {"bib": {"title": "Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response.", "year": "1992"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:KNjnJ3z-R6IC", "citedby": "0"}, {"bib": {"title": "THE ERYTHROMYCIN BREATH TEST SELECTIVELY ASSAYS P450IIIA IN PATIENTS WITH SEVERE LIVER-DISEASE", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_axFR9aDTf0C", "citedby": "0"}, {"bib": {"title": "Antimicosomal antibodies: what are they telling US?", "year": "1991"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:PkcyUWeTMh0C", "citedby": "0"}, {"bib": {"title": "THE ERYTHROMYCIN BREATH TEST AS A MEASURE OF LIVER-FUNCTION", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HbR8gkJAVGIC", "citedby": "0"}, {"bib": {"title": "THE ERYTHROMYCIN BREATH TEST PREDICTS OPTIMAL CYCLOSPORINE DOSE IN KIDNEY AND HEART BUT NOT LIVER-TRANSPLANT RECIPIENTS", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:i2xiXl-TujoC", "citedby": "0"}, {"bib": {"title": "THE ERYTHROMYCIN BREATH TEST PREDICTS CYCLOSPORINE DOSING IN KIDNEY AND HEART BUT NOT LIVER RECIPIENTS", "year": "1990"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:k8Z6L05lTy4C", "citedby": "0"}, {"bib": {"title": "IDIOSYNCRATIC CYCLOSPORINE-A TOXICITY-A CORRECTABLE DEFECT IN CYTOCHROME-P-450IIIA", "year": "1989"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:_OXeSy2IsFwC", "citedby": "0"}, {"bib": {"title": "ERYTHROMYCIN BREATH TEST AND URINE 6-BETA CORTISOL-STUDIES IN 32 PATIENTS AND IN AN ANHEPATIC MAN", "year": "1989"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:rmuvC79q63oC", "citedby": "0"}, {"bib": {"title": "DIFFERENTIAL REGULATION OF P-450P-RELATED PROTEINS IN CIRRHOSIS", "year": "1988"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HeT0ZceujKMC", "citedby": "0"}, {"bib": {"title": "COMPARISON OF 14C ERYTHROMYCIN DEMETHYLATION AND URINARY 6B CORTISOL HYDROXYLATION IN HYPERTENSIVE SUBJECTS", "year": "1988"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:yFnVuubrUp4C", "citedby": "0"}, {"bib": {"title": "THE ERYTHROMYCIN BREATH TEST-A NONINVASIVE ASSAY OF GLUCOCORTICOID-INDUCIBLE LIVER CYTOCHROMES-P-450 IN RAT AND MAN", "year": "1987"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:kuK5TVdYjLIC", "citedby": "0"}, {"bib": {"title": "IDENTIFICATION OF MULTIPLE GLUCOCORTICOID-INDUCIBLE CYTOCHROMES-P-450 AND THEIR MESSENGER-RNA IN RAT INTESTINAL-MUCOSA", "year": "1987"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:2VqYfGB8ITEC", "citedby": "0"}, {"bib": {"title": "HUMAN INTESTINAL-MUCOSA CONTAINS A CYTOCHROME-P-450 INDISTINGUISHABLE FROM HLP", "year": "1987"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:WZBGuue-350C", "citedby": "0"}, {"bib": {"title": "Intrinsic Fluorescence of Elongation Factor Tu in Its Complexes with GDP and Elongation Factor Tst", "year": "1987"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:LPtt_HFRSbwC", "citedby": "0"}, {"bib": {"title": "CHARACTERIZATION AND PURIFICATION OF ETHANOL-INDUCIBLE HUMAN-LIVER N-NITROSODIMETHYLAMINE DEMETHYLASE", "year": "1986"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:a3BOlSfXSfwC", "citedby": "0"}, {"bib": {"title": "IDENTIFICATION OF THE HUMAN HOMOLOG TO RAT-LIVER ISOSAFOLE-INDUCIBLE CYTOCHROME-P-450D", "year": "1986"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:nZcligLrVowC", "citedby": "0"}, {"bib": {"title": "MACROLIDE ANTIBIOTIC INDUCERS OF CYTOCHROME-P-450 PREVENT THE DEGRADATION OF CYTOCHROME-P-450P IN RAT-LIVER", "year": "1985"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:e_rmSamDkqQC", "citedby": "0"}, {"bib": {"title": "Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: A randomized controlled trial.", "year": "1981"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:O0nohqN1r9EC", "citedby": "0"}, {"bib": {"title": "Workshop Report Building Shared Experience to Advance Practical Application of Pathway-Based Toxicology: Liver Toxicity Mode-of-Action"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:zwpXiJ37cpgC", "citedby": "0"}, {"bib": {"title": "A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-fe lodipine interaction."}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:-yGd096yOn8C", "citedby": "0"}, {"bib": {"title": "Toxicological Sciences: an Official Journal of the Society of Toxicology, 01 Feb 2015, 143 (2): 256-267"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:c1e4I3QdEKYC", "citedby": "0"}, {"bib": {"title": "Mechanistic biomarkers of liver safety and benign elevations in serum aminotransferases-A study in healthy volunteer treated with cholestyramine"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:L_l9e5I586QC", "citedby": "0"}, {"bib": {"title": "Case Definition and Phenotype Standardization in Drug-Induced Liver Injury (DILI)"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:RJOyoaXV5v8C", "citedby": "0"}, {"bib": {"title": "Reply (to LTE HEP\u201018\u20100257)"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:jSAVyFp_754C", "citedby": "0"}, {"bib": {"title": "Vaccination in children with HIV infection"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:rbm3iO8VlycC", "citedby": "0"}, {"bib": {"title": "Collaborators and Contributors to case recruitment"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:F2UWTTQJPOcC", "citedby": "0"}, {"bib": {"title": "www. rsc. org/toxicology"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HhcuHIWmDEUC", "citedby": "0"}, {"bib": {"title": "Quantitative Modeling Uncovers a Potential Limitation in the Putative Mechanism of CCl"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:U_HPUtbDl20C", "citedby": "0"}, {"bib": {"title": "ACCELERATED COMMUNICATION"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:CdxZDUztZiMC", "citedby": "0"}, {"bib": {"title": "Mass balance phenotyping of primary human hepatocytes in 2D cultures treated with acetaminophen"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:KbBQZpvPDL4C", "citedby": "0"}, {"bib": {"title": "We would like to thank the following individuals who served as reviewers for abstracts submitted to the American Association for the Study of Liver Diseases 54th Annual Meeting"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:HIFyuExEbWQC", "citedby": "0"}, {"bib": {"title": "Schiff\u2019s Diseases of the Liver 10th Edition"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:OTTXONDVkokC", "citedby": "0"}, {"bib": {"title": "AASLD abstract reviewers"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:0N-VGjzr574C", "citedby": "0"}, {"bib": {"title": "IMAGING AND ADVANCED TECHNOLOGY"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:PoWvk5oyLR8C", "citedby": "0"}, {"bib": {"title": "AASLD postgraduate course meet-the-professor luncheons"}, "source": "citations", "id_citations": "Vc3IaCIAAAAJ:M7yex6snE4oC", "citedby": "0"}]}